So, I should ask:
Did you have no real idea about the option conversion (you forgot to mention this), Nuheara's rebate that was due, and the reduced outgoings ? (Posting incorrect information through lack of knowledge.)
OR
Did you know about these things but post your incorrect cash position estimates anyway? (Seeking to mislead readers.)
It has to be one of the other as you have now admitted that you significantly underestimated the Nuheara cash position - that basis of your post to short.
- Forums
- ASX - By Stock
- NUH
- Ann: NUH Expands Health Research in Auditory Processing Disorders
Ann: NUH Expands Health Research in Auditory Processing Disorders, page-54
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUH (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.75M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online